Dr. Harry Sutton graduated from King's College London and worked as a foundation program doctor in Glasgow, Scotland. He completed his pediatric residency training at Jacobi Medical Center in New York, and his pediatric gastroenterology fellowship at SickKids in Toronto. Harry completed his Master's of Immunology at the University of Toronto where he worked in the MacParland Lab and investigated immune dysfunction in cases of Indeterminate Pediatric Acute Liver Failure. Harry is currently completing an Advanced Transplant Hepatology Fellowship at Children's Hospital Los Angeles.

I completed my internal medicine residency at Boston Medical Center–Brighton, where I also served as chief resident, and my transplant hepatology fellowship at Lahey Clinic. I now practice hepatology in Charleston, West Virginia, and am applying to gastroenterology fellowship.

Jianjun Zhu, MD, is an Associate Chief Physician in the Department of Liver Surgery at Renji Hospital, Shanghai Jiao Tong University School of Medicine. As a transplant surgeon, his clinical practice focuses on liver transplantation and complex hepatobiliary surgery. Dr. Zhu's translational research is centered on ex vivo liver machine perfusion and hepatic ischemia-reperfusion injury, aiming to optimize donor organ preservation and improve post-transplant outcomes.

Sri Harsha Boppana, MD, is a PGY-3 Internal Medicine resident at Nassau University Medical Center (NuHealth) in East Meadow, New York, and a Postdoctoral Research Fellow at Johns Hopkins University School of Medicine. His research focuses on artificial intelligence and machine learning in gastroenterology and hepatology, with particular interest in liver disease outcomes, liver transplantation, and AI-assisted endoscopy and imaging. He has authored more than 45 peer-reviewed publications, over 90 journal abstracts, and 3 book chapters. Dr.

My name is Hui Han. I am a researcher at UIC.

My name is Hong Li. I am currently a PhD student engaged in Research center, Beijing Friendship Hospital, Capital Medical University, Beijing, China. My research focuses on understanding the mechanisms underlying liver fibrosis and exploring potential therapeutic strategies.

Fuchen Dong is a PhD candidate at the University of Groningen and University Medical Center Groningen (UMCG), the Netherlands. He holds a Master of Medicine from Shanghai Jiao Tong University School of Medicine, where his research focused on acute-on-chronic liver failure (ACLF). His clinical research training in hepatology motivated his interest in understanding the mechanisms of liver disease and translating clinically relevant questions into experimental models.